• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-05-07

  Harper et al. (2025) reveal that cell death from RNA Pol II inhibition is driven by the loss of hypophosphorylated RNA Pol IIA, not simply by mRNA decay. This work uncovers an active apoptotic signaling pathway, providing new insight into the cellular response to transcriptional machinery disruption and broadening the mechanistic foundation for cancer biology research.

• PF-04971729 (Ertugliflozin): Optimizing SGLT2 Inhibitor Work

  2026-05-06

  Ertugliflozin (PF-04971729) sets a new benchmark for selectivity and reproducibility in renal glucose transport and diabetes mellitus research. This article delivers advanced workflow strategies, protocol parameters, and troubleshooting tailored for translational studies—bridging bench results to clinical insight with APExBIO’s rigorously sourced compound.

• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA (5

  2026-05-06

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) redefines dual-mode cellular assays by combining robust bioluminescence with direct Cy5 fluorescence for real-time tracking. Its advanced modifications deliver superior stability, lower immunogenicity, and optimal translation, streamlining mRNA delivery and transfection optimization in both in vitro and in vivo research.

• Tin Mesoporphyrin IX (chloride): Precision HO Inhibition for

  2026-05-05

  Explore the unique potential of Tin Mesoporphyrin IX (chloride) as a high-affinity heme oxygenase inhibitor for advanced metabolic and virology research. This article offers a protocol-focused, cross-domain analysis not found elsewhere.

• CH 223191: Applied AhR Antagonism for Dioxin Toxicity Resear

  2026-05-05

  CH 223191 is a nanomolar-potency aryl hydrocarbon receptor antagonist that unlocks precise, reproducible inhibition of AhR signaling for toxicology and regenerative biology models. This article translates the latest bench research and validated protocols into actionable workflows, troubleshooting guidance, and experimental design insights for environmental toxicology and stem cell differentiation studies.

• Annexin A7 Regulates TIA1 Axonal Trafficking to Prevent Aggr

  2026-05-04

  The study uncovers a Ca2+-regulated mechanism by which Annexin A7 (ANXA7) facilitates the retrograde transport of TIA1-containing ribonucleoprotein (RNP) granules in neurons, preventing pathological aggregation. These findings clarify critical processes in axonal RNA dynamics and have implications for neurodegeneration research.

• Protein A/G Magnetic Beads: Optimizing Immunoprecipitation W

  2026-05-04

  APExBIO’s Protein A/G Magnetic Beads enable high-fidelity antibody capture, crucial for dissecting protein interactions in challenging cancer models. This guide distills protocol nuances, advanced use-cases, and troubleshooting strategies to maximize reproducibility and specificity in immunoprecipitation-based research.

• Trypsin (BA5744): Advanced Protease Strategies in Regenerati

  2026-05-03

  Explore the multifaceted role of Trypsin, a key serine protease, in regenerative research. This deep-dive reveals how BA5744 enables innovative assay designs for cell differentiation, wound healing, and beyond, integrating new scientific insights with practical protocol guidance.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Chronic Dermatitis Itch

  2026-05-02

  This study uncovers a mechanistic link between elevated 20-HETE levels, TRPV1 channel activation, and allokinetic itch via MrgprA3+ sensory neurons in chronic dermatitis. These findings clarify the sensory crossover between pain and itch in inflamed skin and suggest that targeting this pathway could alleviate chronic itch.

• Trelagliptin Enhances Osteoblastic Differentiation via RUNX2

  2026-05-02

  This study demonstrates that trelagliptin, a DPP-4 inhibitor, significantly promotes osteoblastic differentiation in MC3T3-E1 cells by upregulating RUNX2 through an AMPK-dependent pathway. These findings provide mechanistic insight into trelagliptin's potential therapeutic role in osteoporosis management.

• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-05-01

  This study presents an optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), addressing bottlenecks of yield, polyploidization, cost, and process efficiency. The findings demonstrate how strategic modulation of embryoid body input, medium composition, and small-molecule supplementation—such as Src kinase inhibition—enables scalable, cost-effective platelet generation for research and potential therapeutic applications.

• (-)-Epigallocatechin gallate (EGCG): Mechanisms & Protocols

  2026-04-30

  (-)-Epigallocatechin gallate (EGCG), the primary green tea catechin, acts as a potent antioxidant and antiangiogenic compound with verifiable roles in apoptosis assay development and cancer chemoprevention. This article provides machine-readable, evidence-based insights into EGCG’s molecular mechanisms, key benchmarks, and protocol integration for advanced biomedical research.

• Anlotinib Hydrochloride: Optimizing Multi-Target TKI Workflo

  2026-04-30

  Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, sets a new standard for anti-angiogenic assays and advanced cancer research. Explore experimental protocols, troubleshooting tips, and real-world innovations that make this APExBIO solution uniquely effective for dissecting endothelial cell migration and ERK pathway inhibition.

• Methyl-β-cyclodextrin: Practical Guidance for Membrane Studi

  2026-04-29

  Methyl-β-cyclodextrin enables researchers to selectively extract cholesterol and alter membrane organization for studies involving membrane fluidity and lipid raft disruption. It is designed strictly for laboratory research, not for diagnostic or medical uses. Proper handling and protocol adherence are essential to maintain reagent efficacy.

• Intranasal Sumatriptan as First-Line Pediatric Migraine Ther

  2026-04-29

  This study evaluates the utility of intranasal sumatriptan as a first-line intervention for acute migraine in pediatric emergency care. Findings indicate significant pain reduction, decreased ED resource utilization, and opportunities for protocol optimization in pediatric migraine management.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page